These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6356556)

  • 1. [Prevention of recurrence in non-invasive bladder carcinoma. Experiences with 400 patients].
    Burk K; Troller RM; Pittner P
    Urologe A; 1983 Sep; 22 Suppl():332-6. PubMed ID: 6356556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early adjuvant adriamycin in superficial bladder carcinoma.
    Schulman CC; Denis LJ; Costerlinck W; De Sy W; Chantrie M; Bouffioux C; Van Cangh PJ; Van Erps P; De Sloover C
    Prog Clin Biol Res; 1984; 162B():151-62. PubMed ID: 6390444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized study of single early instillation of (2"R)-4'-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma.
    Okamura K; Ono Y; Kinukawa T; Matsuura O; Yamada S; Ando T; Fukatsu T; Ohno Y; Ohshima S;
    Cancer; 2002 May; 94(9):2363-8. PubMed ID: 12015761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum uptake of doxorubicin intravesically administered soon after transurethral resection of bladder carcinoma].
    Nagakura K; Takao M; Odajima K; Ieda K; Fujioka T; Hayakawa M; Murai M; Nakamura H
    Hinyokika Kiyo; 1989 Sep; 35(9):1509-12. PubMed ID: 2816617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin].
    Flamm J; Grof F
    Urologe A; 1985 Jan; 24(1):31-5. PubMed ID: 4039083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors].
    Maier U; Kuber W
    Fortschr Med; 1983 Mar; 101(12):535-40. PubMed ID: 6852720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized study on intravesical pirarubicin (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer].
    Miki T; Nonomura N; Kojima Y; Okuyama A; Nakano E; Kiyohara H; Fujioka H; Koide T; Wakatsuki A; Kuroda H; Sugao H; Seguti T; Takeyama M; Yamaguchi S
    Hinyokika Kiyo; 1997 Dec; 43(12):907-12. PubMed ID: 9488944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of bladder cancer with intravesical instillation of adriamycin.
    Pavone-Macaluso M; Ingargiola GB; Tripi M; Lamartina M
    Prog Clin Biol Res; 1984; 162B():181-91. PubMed ID: 6390445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
    Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M
    Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes.
    Liu B; Wang Z; Chen B; Yu J; Zhang P; Ding Q; Zhang Y
    Cancer Invest; 2006 Mar; 24(2):160-3. PubMed ID: 16537185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tur vs TUR plus adriamycin in patients with superficial bladder cancer--a five-year follow-up.
    Burk K; Schultze-Seemann W; Rodeck G
    Prog Clin Biol Res; 1989; 303():417-22. PubMed ID: 2780656
    [No Abstract]   [Full Text] [Related]  

  • 12. [A randomized study of prophylactic intravesical instillation of pirarubicin (THP) prior to transurethral resection of superficial bladder cancer].
    Hashimura T; Shirahase T; Inoue T; Yamasaki T; Terada N; Ogura K; Arai Y; Hida S; Ueda T
    Hinyokika Kiyo; 2005 Jul; 51(7):439-42. PubMed ID: 16119805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer.
    Jauhiainen K; Alfthan O
    Ann Chir Gynaecol; 1984; 73(4):206-10. PubMed ID: 6508201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences on the local adriamycin treatment of bladder tumours.
    Somogyi L; Török A; Bors G; Frang D
    Acta Chir Hung; 1987; 28(2):79-85. PubMed ID: 3618056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postoperative intravesical installation of tetrahydropyranyl-adriamycin (THP) and cytosine arabinoside (CA) for superficial bladder cancer: clinical results of prophylactic effects on recurrence].
    Hashimoto H; Yachiku S; Watabe Y; Niibori D; Yamauchi K; Osanai H; Ohashi K; Wakabayashi A; Fujisawa M
    Gan To Kagaku Ryoho; 1994 May; 21(6):833-8. PubMed ID: 8185341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunomodulating effect of interferon-gamma intravesical instillations in preventing bladder cancer recurrence.
    Giannopoulos A; Constantinides C; Fokaeas E; Stravodimos C; Giannopoulou M; Kyroudi A; Gounaris A
    Clin Cancer Res; 2003 Nov; 9(15):5550-8. PubMed ID: 14654535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy.
    Chang SG; Lee SJ; Huh JS; Lee JH
    Oncol Rep; 2001; 8(2):257-61. PubMed ID: 11182036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
    Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y;
    Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adriamycin versus ftorafur in the prevention of recurrence of superficial carcinoma of the bladder].
    Unda Urzaiz M; Zubiaur Líbano C; Pérez Fernández A; Iriarte Soldevilla JI; Flores Corral N
    Arch Esp Urol; 1990 Mar; 43(2):143-6. PubMed ID: 2114069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.
    Gudjónsson S; Adell L; Merdasa F; Olsson R; Larsson B; Davidsson T; Richthoff J; Hagberg G; Grabe M; Bendahl PO; Månsson W; Liedberg F
    Eur Urol; 2009 Apr; 55(4):773-80. PubMed ID: 19153001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.